Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.

Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR.

Cancer Med. 2019 Nov 12. doi: 10.1002/cam4.2685. [Epub ahead of print]

2.

Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy.

Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1917-1925. doi: 10.1158/1055-9965.EPI-19-0488. Epub 2019 Aug 28.

PMID:
31462398
3.

Diet and lifestyle considerations for patients with prostate cancer.

Zuniga KB, Chan JM, Ryan CJ, Kenfield SA.

Urol Oncol. 2019 Jul 18. pii: S1078-1439(19)30247-9. doi: 10.1016/j.urolonc.2019.06.018. [Epub ahead of print] Review.

PMID:
31327752
4.

Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.

Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM.

J Urol. 2019 May 15:101097JU0000000000000336. doi: 10.1097/JU.0000000000000336. [Epub ahead of print]

PMID:
31091175
5.

Alcohol Intake and Risk of Lethal Prostate Cancer in the Health Professionals Follow-Up Study.

Downer MK, Kenfield SA, Stampfer MJ, Wilson KM, Dickerman BA, Giovannucci EL, Rimm EB, Wang M, Mucci LA, Willett WC, Chan JM, Van Blarigan EL.

J Clin Oncol. 2019 Jun 10;37(17):1499-1511. doi: 10.1200/JCO.18.02462. Epub 2019 Apr 26.

PMID:
31026211
6.

Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.

Downer MK, Allard CB, Preston MA, Wilson KM, Kenfield SA, Chan JM, Mucci LA, Giovannucci E, Stampfer MJ.

Eur Urol Oncol. 2019 Mar;2(2):126-134. doi: 10.1016/j.euo.2018.07.002. Epub 2018 Jul 31.

PMID:
31017087
7.

Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial.

Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP.

BMC Cancer. 2019 Mar 11;19(1):218. doi: 10.1186/s12885-019-5427-5.

8.

Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer.

Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM.

Eur Urol. 2019 Jun;75(6):950-958. doi: 10.1016/j.eururo.2018.12.040. Epub 2019 Jan 10.

PMID:
30638635
9.

Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial.

Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM.

JMIR Res Protoc. 2018 Nov 15;7(11):e11257. doi: 10.2196/11257.

10.

Association of Statin Use With Overall and Cancer Survival.

Chan JM, Kenfield SA, Platz EA.

JAMA Oncol. 2018 Jul 1;4(7):1016. doi: 10.1001/jamaoncol.2018.0730. No abstract available.

PMID:
29800037
11.

Intense Exercise for Survival among Men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol.

Newton RU, Kenfield SA, Hart NH, Chan JM, Courneya KS, Catto J, Finn SP, Greenwood R, Hughes DC, Mucci L, Plymate SR, Praet SFE, Guinan EM, Van Blarigan EL, Casey O, Buzza M, Gledhill S, Zhang L, Galvão DA, Ryan CJ, Saad F.

BMJ Open. 2018 May 14;8(5):e022899. doi: 10.1136/bmjopen-2018-022899.

12.

Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study.

Bauer SR, Van Blarigan EL, Stampfer MJ, Chan JM, Kenfield SA.

Prostate. 2018 Feb;78(3):202-212. doi: 10.1002/pros.23457. Epub 2017 Dec 1.

13.

Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells.

Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA.

Prostate. 2018 Feb;78(3):233-238. doi: 10.1002/pros.23462. Epub 2017 Nov 22.

14.

Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™).

Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM.

Prostate. 2018 Jan;78(1):32-39. doi: 10.1002/pros.23441. Epub 2017 Nov 6.

15.

The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study.

Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan JM.

JMIR Cancer. 2017 Apr 18;3(1):e5. doi: 10.2196/cancer.6935.

16.

Exercise-induced biochemical changes and their potential influence on cancer: a scientific review.

Thomas RJ, Kenfield SA, Jimenez A.

Br J Sports Med. 2017 Apr;51(8):640-644. doi: 10.1136/bjsports-2016-096343. Epub 2016 Dec 19. Review.

17.

Prostate cancer progression and mortality: a review of diet and lifestyle factors.

Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA.

World J Urol. 2017 Jun;35(6):867-874. doi: 10.1007/s00345-016-1914-3. Epub 2016 Aug 12. Review.

18.

Blood fatty acid patterns are associated with prostate cancer risk in a prospective nested case-control study.

Yang M, Ayuningtyas A, Kenfield SA, Sesso HD, Campos H, Ma J, Stampfer MJ, Chavarro JE.

Cancer Causes Control. 2016 Sep;27(9):1153-61. doi: 10.1007/s10552-016-0794-6. Epub 2016 Aug 3.

19.

Nut consumption and prostate cancer risk and mortality.

Wang W, Yang M, Kenfield SA, Hu FB, Stampfer MJ, Willett WC, Fuchs CS, Giovannucci EL, Bao Y.

Br J Cancer. 2016 Jul 26;115(3):371-4. doi: 10.1038/bjc.2016.181. Epub 2016 Jun 9.

20.

Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.

Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA.

Am J Clin Nutr. 2016 Mar;103(3):851-60. doi: 10.3945/ajcn.115.118703. Epub 2016 Jan 27.

21.

Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer.

Kenfield SA, Batista JL, Jahn JL, Downer MK, Van Blarigan EL, Sesso HD, Giovannucci EL, Stampfer MJ, Chan JM.

J Natl Cancer Inst. 2015 Nov 17;108(3). pii: djv329. doi: 10.1093/jnci/djv329. Print 2016 Mar.

22.

Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study.

Van Blarigan EL, Gerstenberger JP, Kenfield SA, Giovannucci EL, Stampfer MJ, Jones LW, Clinton SK, Chan JM, Mucci LA.

Cancer Prev Res (Phila). 2015 Oct;8(10):962-967. doi: 10.1158/1940-6207.CAPR-15-0132. Epub 2015 Aug 14.

23.

Prostate Cancer Progression: The Smoking Gun?

Kenfield SA, Stampfer MJ.

Eur Urol. 2015 Dec;68(6):957-8. doi: 10.1016/j.eururo.2015.07.046. Epub 2015 Aug 5. No abstract available.

PMID:
26254511
24.

Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study.

Chan JM, Kenfield SA, Paciorek A, Platz EA, Giovannucci EL, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1638-40. doi: 10.1158/1055-9965.EPI-15-0671. Epub 2015 Jul 19.

25.

Fat intake after prostate cancer diagnosis and mortality in the Physicians' Health Study.

Van Blarigan EL, Kenfield SA, Yang M, Sesso HD, Ma J, Stampfer MJ, Chan JM, Chavarro JE.

Cancer Causes Control. 2015 Aug;26(8):1117-26. doi: 10.1007/s10552-015-0606-4. Epub 2015 Jun 6.

26.

Dietary patterns after prostate cancer diagnosis in relation to disease-specific and total mortality.

Yang M, Kenfield SA, Van Blarigan EL, Batista JL, Sesso HD, Ma J, Stampfer MJ, Chavarro JE.

Cancer Prev Res (Phila). 2015 Jun;8(6):545-51. doi: 10.1158/1940-6207.CAPR-14-0442.

27.

Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.

Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Van Blarigan EL, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, De Marzo AM, Meeker AK, Platz EA.

Cancer Prev Res (Phila). 2015 Aug;8(8):737-42. doi: 10.1158/1940-6207.CAPR-15-0097. Epub 2015 May 19.

28.

Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality.

Yang M, Kenfield SA, Van Blarigan EL, Wilson KM, Batista JL, Sesso HD, Ma J, Stampfer MJ, Chavarro JE.

Int J Cancer. 2015 Nov 15;137(10):2462-9. doi: 10.1002/ijc.29608. Epub 2015 Jun 3.

29.

Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study.

Phillips SM, Stampfer MJ, Chan JM, Giovannucci EL, Kenfield SA.

J Cancer Surviv. 2015 Sep;9(3):500-11. doi: 10.1007/s11764-015-0426-2. Epub 2015 Apr 16.

30.

Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study.

Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll PR, Hernán MA.

Eur J Cancer. 2015 May;51(7):817-24. doi: 10.1016/j.ejca.2015.03.003. Epub 2015 Mar 17.

31.

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.

Graff RE, Pettersson A, Lis RT, DuPre N, Jordahl KM, Nuttall E, Rider JR, Fiorentino M, Sesso HD, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Nguyen PL, Sweeney CJ, Mucci LA; Transdisciplinary Prostate Cancer Partnership ToPCaP.

Prostate. 2015 Jun 15;75(9):897-906. doi: 10.1002/pros.22973. Epub 2015 Mar 1.

32.

Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up Study.

Platz EA, Drake CG, Wilson KM, Sutcliffe S, Kenfield SA, Mucci LA, Stampfer MJ, Willett WC, Camargo CA Jr, Giovannucci E.

Int J Cancer. 2015 Aug 15;137(4):949-58. doi: 10.1002/ijc.29463. Epub 2015 Feb 27.

33.

Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Breyer BN, Huang WY, Rabkin CS, Alderete JF, Pakpahan R, Beason TS, Kenfield SA, Mabie J, Ragard L, Wolin KY, Grubb RL 3rd, Andriole GL, Sutcliffe S.

BJU Int. 2016 Jan;117(1):145-54. doi: 10.1111/bju.13050. Epub 2015 Apr 23.

34.

Selenium supplementation and prostate cancer mortality.

Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, L Giovannucci E, Chan JM.

J Natl Cancer Inst. 2014 Dec 12;107(1):360. doi: 10.1093/jnci/dju360. Print 2015 Jan.

35.

Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.

Cao Y, Nimptsch K, Shui IM, Platz EA, Wu K, Pollak MN, Kenfield SA, Stampfer MJ, Giovannucci EL.

Int J Cancer. 2015 May 15;136(10):2418-26. doi: 10.1002/ijc.29295. Epub 2014 Nov 10.

36.

Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.

Van Blarigan EL, Ma J, Kenfield SA, Stampfer MJ, Sesso HD, Giovannucci EL, Witte JS, Erdman JW Jr, Chan JM, Penney KL.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1037-46. doi: 10.1158/1055-9965.EPI-13-0670. Epub 2014 Apr 7.

37.

What should we tell prostate cancer patients about (secondary) prevention?

Chan JM, Van Blarigan EL, Kenfield SA.

Curr Opin Urol. 2014 May;24(3):318-23. doi: 10.1097/MOU.0000000000000049. Review.

38.

Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study.

Alemozaffar M, Sanda M, Yecies D, Mucci LA, Stampfer MJ, Kenfield SA.

Eur Urol. 2015 Mar;67(3):432-8. doi: 10.1016/j.eururo.2014.01.039. Epub 2014 Feb 11.

39.

The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey.

Breyer BN, Kenfield SA, Blaschko SD, Erickson BA.

J Urol. 2014 May;191(5):1333-9. doi: 10.1016/j.juro.2013.12.012. Epub 2013 Dec 14.

40.

Selective angioembolization for traumatic renal injuries: a survey on clinician practice.

Glass AS, Appa AA, Kenfield SA, Bagga HS, Blaschko SD, McGeady JB, McAninch JW, Breyer BN.

World J Urol. 2014 Jun;32(3):821-7. doi: 10.1007/s00345-013-1169-1. Epub 2013 Sep 27.

41.

Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancer.

Chavarro JE, Kenfield SA, Stampfer MJ, Loda M, Campos H, Sesso HD, Ma J.

Am J Epidemiol. 2013 Oct 15;178(8):1246-55. doi: 10.1093/aje/kwt136. Epub 2013 Aug 28.

42.

Healthy behaviours yield major benefits in ageing.

Kenfield SA, Stampfer MJ.

BMJ. 2013 Aug 20;347:f5156. doi: 10.1136/bmj.f5156. No abstract available.

PMID:
23963560
43.

Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study.

Kenfield SA, DuPre N, Richman EL, Stampfer MJ, Chan JM, Giovannucci EL.

Eur Urol. 2014 May;65(5):887-94. doi: 10.1016/j.eururo.2013.08.009. Epub 2013 Aug 13.

44.

Total antioxidant intake in relation to prostate cancer incidence in the Health Professionals Follow-Up Study.

Russnes KM, Wilson KM, Epstein MM, Kasperzyk JL, Stampfer MJ, Kenfield SA, Smeland S, Blomhoff R, Giovannucci EL, Willett WC, Mucci LA.

Int J Cancer. 2014 Mar 1;134(5):1156-65. doi: 10.1002/ijc.28438. Epub 2013 Nov 11.

45.

Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.

Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL, De Marzo AM, Platz EA, Meeker AK.

Cancer Discov. 2013 Oct;3(10):1130-41. doi: 10.1158/2159-8290.CD-13-0135. Epub 2013 Jun 18.

46.

Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality.

Richman EL, Kenfield SA, Chavarro JE, Stampfer MJ, Giovannucci EL, Willett WC, Chan JM.

JAMA Intern Med. 2013 Jul 22;173(14):1318-26. doi: 10.1001/jamainternmed.2013.6536.

47.

Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era.

Glass AS, Cowan JE, Fuldeore MJ, Cooperberg MR, Carroll PR, Kenfield SA, Greene KL.

Urology. 2013 Jul;82(1):60-5. doi: 10.1016/j.urology.2013.01.072. Epub 2013 May 21.

48.

A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.

Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA.

Clin Cancer Res. 2013 Mar 15;19(6):1612-9. doi: 10.1158/1078-0432.CCR-12-2718. Epub 2013 Feb 4.

49.

Smoking, smoking cessation, and risk of sudden cardiac death in women.

Sandhu RK, Jimenez MC, Chiuve SE, Fitzgerald KC, Kenfield SA, Tedrow UB, Albert CM.

Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1091-7. doi: 10.1161/CIRCEP.112.975219. Epub 2012 Dec 11.

50.

Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.

Dhillon PK, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM.

Cancer Prev Res (Phila). 2012 Oct;5(10):1223-8. doi: 10.1158/1940-6207.CAPR-12-0171. Epub 2012 Sep 7.

Supplemental Content

Loading ...
Support Center